Please wait a minute...
Frontiers of Medicine

ISSN 2095-0217

ISSN 2095-0225(Online)

CN 11-5983/R

Postal Subscription Code 80-967

2018 Impact Factor: 1.847

Front. Med.    2009, Vol. 3 Issue (4) : 437-442     DOI: 10.1007/s11684-009-0074-x
Research articles |
The role of natriuretic peptide precursor A gene polymorphism in the development of coronary heart disease in Chinese Han population?
Ripen NSENGA MD1,Longxian CHENG PhD1,Mei’an HE PhD2,Tangchun WU PhD2,
1.Department of Cardiology, Union Hospital, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430022, China; 2.Institute of Occupational Medicine, Tongji Medical College, Huazhong University of Science and Technology, Wuhan 430030, China;
Download: PDF(98 KB)  
Export: BibTeX | EndNote | Reference Manager | ProCite | RefWorks
Abstract  Natriuretic peptide precursor A (NPPA) is synthesized, stored, and released by atrial myocytes. Previous studies have shown that NPPA plays a significant role in the regulation of coronary circulation and in atherosclerosis. Rs5065 NPPA gene polymorphism leads to the translation of NPPA with two additional arginines and has been suggested to be associated with salt-sensitive hypertension. The purpose of the present study was to investigate the relationship between the rs5065 NPPA gene polymorphism and the risk of coronary heart disease (CHD) in Chinese Han population. We genotyped the single nucleotide polymorphism (SNP) rs5065 NPPA in the human NPPA gene in 1861 sex- and age-matched subjects, comprising of 904 CHD cases and 957 controls of Chinese Han population. Genotyping of SNP was performed with Taqman SNP allelic discrimination assays by means of an ABI 7900HT. Our study showed that the frequencies of rs5065 NPPA C allele in the case and the control groups were 0.012 and 0.005, respectively. There was significant difference in C allele frequency distribution between the two groups (OR=2.607, 95% CI: 1.197−5.678, P=0.012). In the case group, there was significant difference between smokers and nonsmokers with subjects carrying C allele (P=0.037), and no significant difference in gender, age, fasting total cholesterol (TC), triglycerides (TG), fasting plasma glucose (FPG), body mass index (BMI), and blood pressure (BP) between the cases and the controls (P>0.05). Our results suggest that the C allele of rs5065 NPPA gene polymorphism may be associated with the risk of CHD.
Keywords natriuretic peptide precursor A      coronary heart disease      gene polymorphism      allelic discrimination      polymorphism, single nucleotide      
Issue Date: 05 December 2009
URL:     OR
de Bold A J, Borenstein H B, Veress A T, Sonnenberg H. A rapid and potent natriuretic response to intravenous injectionof atrial myocardial extracts in rats. Life Sci, 1981, 28(1): 89―94

doi: 10.1016/0024-3205(81)90370-2
Nishikimi T, Mori Y, Ishimura K, Tadokoro K, Yagi H, Yabe A, Horinaka S, Matsuoka H. Association of plasma atrialnatriuretic peptide, N-terminal proatrial natriuretic peptide, andbrain natriuretic peptide levels with coronary artery stenosis inpatients with normal left ventricular systolic function. Am J Med, 2004, 116(8): 517―523

doi: 10.1016/j.amjmed.2003.12.022
Tremblay J, Desjardins R, Hum D, Gutkowska J, Hamet P. Biochemistry and physiologyof the natriuretic peptide receptor guanylyl cyclases. Mol Cell Biochem, 2002, 230(1,2): 31―47
Young J L, Libby P, Schönbeck U. Cytokines in the pathogenesis of. atherosclerosis. Thromb Haemost, 2002, 88(4): 554―567
Kook H, Itoh H, Choi B S, Sawada N, Doi K, Hwang T J, Kim K K, Arai H, Baik Y H, Nakao K. Physiological concentration of atrialnatriuretic peptide induces endothelial regeneration in vitro. Am J Physiol Heart Circ Physiol, 2003, 284(4): H1388―H1397
Libby P. Inflammation in atherosclerosis. Nature, 2002, 420(6917): 868―874

doi: 10.1038/nature01323
Pedram A, Razandi M, Levin E R. Deciphering vascular endothelial cell growth factor/vascularpermeability factor signaling to vascular permeability-inhibited byatrial natriuretic peptide. J Biol Chem, 2002, 277(46): 44385―44398

doi: 10.1074/jbc.M202391200
Raines E W, Ross R. Biology of atheroscleroticplaque formation: possible role of growth factors in lesion developmentand the potential impact of Soy. J Nutr, 1995, 125(3 Suppl): 624S―630S
Kiemer A K,Weber N C, Fürst R, Bildner N, Kulhanek Heinze S, Vollmar A M. Inhibition of p38 MAPK activation via induction of MKP-1:atrial natriuretic peptide reduces TNF-alpha-induced actin polymerizationand endothelial permeability. Circ Res, 2002, 90(8): 874―881

doi: 10.1161/01.RES.0000017068.58856.F3
Okawa H, Horimoto H, Mieno S, Nomura Y, Yoshida M, Shinjiro S. Preischemic infusion of alpha-human atrial natriuretic peptide elicitsmyoprotective effects against ischemia reperfusion in isolated rathearts. Mol Cell Biochem, 2003, 248(1,2): 171―177
Hirata K, Akita H, Yokoyama M, Watanabe Y. Impaired vasodilatory response to atrial natriuretic peptide duringatherosclerosis progression. AtherosclerThromb Vasc Biol, 1992, 12(1): 99―105
Ciechanowicz A, Kurzawski G, Widecka K, Goździk J, Adler G, Czekalski S. Mutation T-->C of nucleotide 2238 in the gene of atrialnatriuretic peptide (ANP) precursor and heterogeneity of sodium-sensitivehypertension. Preliminary report. Pol ArchMed Wew, 1997, 98(12): 501―509
Masharani U, Nakashima P F, Lim D W, Frossard P M. NsiI and ScaI restriction fragment length polymorphisms at the atrialnatriuretic peptide (ANP) gene locus. HumGenet, 1988, 80(3): 307―312

doi: 10.1007/BF01790105
Zorc-Plesković R, Bidovec M, Bregar D, Milutinović A, Terzić R, Teran N. The ScaI gene polymorphism of the atrial natriureticfactor and essential arterial hypertension in childhood. Coll Antropol, 2004, 28(2): 617―621
Ramasawmy R, Kotea N, Lu C Y, Sayada C, Baligadoo S, Krishnamoorthy R. Investigation of the polymorphic ScaI site by a PCR-based assay at the human atrial natriuretic peptides(hANP) gene locus. Hum Genet, 1992, 90(3): 323―324

doi: 10.1007/BF00220093
Gruchala M, Ciećwierz D, Wasag B, Targoński R, Dubaniewicz W, Nowak A, Sobiczewski W, Ochman K, Romanowski P, Limon J, Rynkiewicz A. Association of the ScaI atrialnatriuretic peptide gene polymorphism with nonfatal myocardial infarctionand extent of coronary artery disease. Am Heart J, 2003, 145(1): 125―131

doi: 10.1067/mhj.2003.52
Roussel R, Trégouët D A, Hadjadj S, Jeunemaître X, Marre M. Investigation of the HumanANP Gene in Type 1 Diabetic Nephropathy. Diabetes, 2004, 53(5): 1394―1398

doi: 10.2337/diabetes.53.5.1394
Rahmutula D, Nakayama T, Soma M, Takahashi Y, Kunimoto M, Uwabo J, Sato M, Izumi Y, Kanmatsuse K, Ozawa Y. Association study betweenthe variants of the human ANP gene and essential hypertension. Hypertens Res, 2001, 24(3): 291―294

doi: 10.1291/hypres.24.291
Nannipieri M, Manganiello M, Pezzatini A, Bellis A D, Seghieri G, Ferrannini E. Polymorphisms in the hANP(human atrial natriuretic peptide) gene, albuminuria, and hypertension. Hypertension, 2001, 37(6): 1416―1422
Rutledge D R, Sun Y, Ross E A. Polymorphism within the atrial natriuretic peptide genein essential hypertension. J Hypertens, 1995, 13(9): 953―955

doi: 10.1097/00004872-199509000-00003
Birkenfeld A L, Boschmann M, Moro C, Adams F, Heusser K, Franke G, Berlan M, Luft F C, Lafontan M, Jordan J. Lipid mobilization with physiologicalatrial natriuretic peptide concentrations in humans. J Clin Endocrinol Metab, 2005, 90(6): 3622―3628

doi: 10.1210/jc.2004-1953
Sengenes C, Stich V, Berlan M, Hejnova J, Lafontan M, Pariskova Z, Galitzky J. Increased lipolysis in adipose tissue and lipid mobilization to natriureticpeptides during low-calorie diet in obese women. Int J Obes, 2002, 26(1): 24―32

doi: 10.1038/sj.ijo.0801845
Dedoussis G V, Maumus S S, koumas J, Choumerianou D M, Pitsavos C, Stefanadis C, Visvikis-Siest S. Natriuretic peptide Val7Met substitutionand risk of coronary artery disease in Greek patients with familialhypercholesterolemia. J Clin Lab Anal, 2006, 20(3): 98―104

doi: 10.1002/jcla.20108
Mango R, Clementi F, Borgiani P, Forleo G B, Federici M, Contino G, Giardina E, Garza L, Fahdi I E, Lauro R, Mehta J L, Novelli G, Romeo F. Association of single nucleotide polymorphisms in theoxidised LDL receptor 1 (OLR1) gene in patients with acute myocardialinfarction. J Med Genet, 2003, 40(12): 933―936

doi: 10.1136/jmg.40.12.933
[1] Xiu-Liang TAO MM, Sheng-Hao TU MD, Ri-Bo XIONG MM, Yong-Hong HU BM, . Inhibition of TNF-alpha secretion from peripheral blood monocular cells by triptolid is associated with TNF-alpha-308 gene polymorphisms in rheumatoid arthritis patients[J]. Front. Med., 2010, 4(2): 220-224.
Full text